Share Price and Basic Stock Data
Last Updated: January 21, 2026, 7:22 pm
| PEG Ratio | 0.32 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Bazel International Ltd operates as a Non-Banking Financial Company (NBFC) and has demonstrated notable revenue growth in recent quarters. The company reported sales of ₹0.29 Cr in September 2022, which rose to ₹1.37 Cr by June 2023. However, a decline was observed in the subsequent quarter, with sales falling to ₹1.15 Cr in September 2023. The company is expected to experience significant revenue growth, with a remarkable spike to ₹13.99 Cr projected for March 2024. Over the past several years, Bazel’s annual sales have fluctuated, with a reported ₹2.02 Cr for the fiscal year ending March 2023, compared to ₹1.15 Cr in March 2022. The trailing twelve-month (TTM) revenue stood at ₹5.37 Cr, suggesting a rebound following the recent dip. This growth trajectory indicates Bazel’s potential to capitalize on market opportunities, although its revenue remains below many sector peers, reflecting a cautious market position.
Profitability and Efficiency Metrics
The profitability metrics for Bazel International Ltd reveal a mixed performance, with notable operating profit margins. Operating Profit Margin (OPM) stood at an impressive 78.76% as of September 2025, showcasing the company’s ability to maintain high profitability relative to its sales. However, the past quarters exhibited volatility, with OPM swinging from -286.09% in September 2023 to 82.81% in December 2023. The company’s net profit recorded a significant loss of ₹3.57 Cr in September 2023, followed by a recovery to ₹0.86 Cr in December 2023. The interest coverage ratio (ICR) was reported at 2.73x, indicating that Bazel is able to cover its interest expenses, albeit with limited room for error. Return on Equity (ROE) was 3.04%, while Return on Capital Employed (ROCE) stood at 3.78%, both of which are below industry averages, suggesting room for improvement in capital efficiency and shareholder returns.
Balance Sheet Strength and Financial Ratios
Bazel International Ltd’s balance sheet reflects a growing asset base, with total assets reported at ₹77.33 Cr as of September 2025. The company’s reserves have increased significantly to ₹53.10 Cr, which is a positive indicator of financial stability. Total borrowings rose to ₹19.95 Cr, suggesting increased leverage, but the Debt to Equity ratio remains relatively low at 0.40, indicating a conservative approach to financing. Financial ratios reveal a Price to Book Value (P/BV) of 0.36x, which suggests that the stock may be undervalued compared to its net assets. The current ratio of 3.11x indicates a strong liquidity position, allowing Bazel to meet short-term obligations comfortably. However, the Cash Conversion Cycle (CCC) at 1,204.61 days raises concerns about operational efficiency, as it suggests delays in converting investments into cash flows, which could impact liquidity in the future.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Bazel International Ltd indicates a high public ownership at 92.05%, reflecting strong retail investor interest. Promoter holdings have declined to 0.11%, which may raise concerns regarding management commitment and confidence. The number of shareholders has increased to 797, suggesting growing interest and participation from the investing community. However, the presence of a significant proportion of public shareholders and the gradual decline of promoter stake could lead to volatility in stock performance. The absence of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) in the shareholding structure may limit institutional backing and further institutional investment. This dynamic could affect stock liquidity and long-term price stability as the company navigates growth challenges.
Outlook, Risks, and Final Insight
Looking ahead, Bazel International Ltd presents both opportunities and risks. The anticipated revenue growth, as indicated by the spike to ₹13.99 Cr in March 2024, could position the company for a stronger market presence. However, the volatility in profitability metrics and the extended Cash Conversion Cycle raise concerns about operational efficiency and financial management. Additionally, the declining promoter stake could affect investor sentiment negatively if perceived as a lack of confidence in the company’s future. Potential risks include increased competition in the NBFC sector, which may pressure margins, and the need to improve operational efficiencies to sustain growth. If Bazel can effectively manage these challenges while leveraging its strong asset base, it may enhance its market position and shareholder value significantly.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minolta Finance Ltd | 14.5 Cr. | 1.45 | 1.81/1.00 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 | |
| Money Masters Leasing & Finance Ltd | 7.13 Cr. | 0.71 | 7.05/0.62 | 21.0 | 1.57 | 0.00 % | 4.42 % | 3.94 % | 1.00 |
| Moneyboxx Finance Ltd | 354 Cr. | 54.7 | 125/53.9 | 40.1 | 0.00 % | 8.65 % | 0.58 % | 10.0 | |
| Moongipa Capital Finance Ltd | 14.0 Cr. | 15.3 | 25.9/15.0 | 11.6 | 26.6 | 0.00 % | 12.1 % | 9.43 % | 10.0 |
| Morarka Finance Ltd | 28.6 Cr. | 63.4 | 146/60.2 | 15.4 | 238 | 1.58 % | 2.46 % | 2.17 % | 10.0 |
| Industry Average | 27,990.81 Cr | 393.77 | 50.96 | 515.00 | 0.24% | 15.81% | 8.84% | 8.50 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.29 | 0.54 | 0.88 | 1.37 | 1.15 | 1.28 | 13.99 | 0.75 | 0.83 | 0.77 | 2.43 | 1.04 | 1.13 |
| Expenses | 0.15 | 0.18 | 2.04 | 0.19 | 4.44 | 0.22 | 12.11 | 0.21 | 0.18 | 0.23 | 1.36 | 0.24 | 0.24 |
| Operating Profit | 0.14 | 0.36 | -1.16 | 1.18 | -3.29 | 1.06 | 1.88 | 0.54 | 0.65 | 0.54 | 1.07 | 0.80 | 0.89 |
| OPM % | 48.28% | 66.67% | -131.82% | 86.13% | -286.09% | 82.81% | 13.44% | 72.00% | 78.31% | 70.13% | 44.03% | 76.92% | 78.76% |
| Other Income | 0.00 | 0.11 | 0.04 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.03 | 0.85 | 0.06 | 0.00 |
| Interest | 0.02 | 0.28 | 0.37 | 0.01 | 0.01 | 0.01 | 0.23 | 0.09 | 0.00 | 0.24 | 0.34 | 0.23 | 0.19 |
| Depreciation | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.10 | 0.03 | 0.03 | 0.03 | 0.10 | 0.03 | -0.02 |
| Profit before tax | 0.12 | 0.19 | -1.50 | 1.16 | -3.31 | 1.04 | 1.58 | 0.42 | 0.62 | 0.30 | 1.48 | 0.60 | 0.72 |
| Tax % | 25.00% | 26.32% | -6.00% | 25.86% | 7.55% | 18.27% | -39.87% | 21.43% | -4.84% | 26.67% | 33.11% | 26.67% | 26.39% |
| Net Profit | 0.08 | 0.14 | -1.41 | 0.86 | -3.57 | 0.86 | 2.20 | 0.33 | 0.65 | 0.22 | 0.99 | 0.44 | 0.53 |
| EPS in Rs | 0.55 | 0.96 | -7.23 | 4.41 | -18.30 | 4.41 | 11.28 | 1.69 | 3.33 | 1.13 | 3.55 | 1.58 | 1.90 |
Last Updated: December 27, 2025, 9:37 pm
Below is a detailed analysis of the quarterly data for Bazel International Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1.13 Cr.. The value appears strong and on an upward trend. It has increased from 1.04 Cr. (Jun 2025) to 1.13 Cr., marking an increase of 0.09 Cr..
- For Expenses, as of Sep 2025, the value is 0.24 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.24 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.89 Cr.. The value appears strong and on an upward trend. It has increased from 0.80 Cr. (Jun 2025) to 0.89 Cr., marking an increase of 0.09 Cr..
- For OPM %, as of Sep 2025, the value is 78.76%. The value appears strong and on an upward trend. It has increased from 76.92% (Jun 2025) to 78.76%, marking an increase of 1.84%.
- For Other Income, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.06 Cr. (Jun 2025) to 0.00 Cr., marking a decrease of 0.06 Cr..
- For Interest, as of Sep 2025, the value is 0.19 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.23 Cr. (Jun 2025) to 0.19 Cr., marking a decrease of 0.04 Cr..
- For Depreciation, as of Sep 2025, the value is -0.02 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.03 Cr. (Jun 2025) to -0.02 Cr., marking a decrease of 0.05 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.72 Cr.. The value appears strong and on an upward trend. It has increased from 0.60 Cr. (Jun 2025) to 0.72 Cr., marking an increase of 0.12 Cr..
- For Tax %, as of Sep 2025, the value is 26.39%. The value appears to be improving (decreasing) as expected. It has decreased from 26.67% (Jun 2025) to 26.39%, marking a decrease of 0.28%.
- For Net Profit, as of Sep 2025, the value is 0.53 Cr.. The value appears strong and on an upward trend. It has increased from 0.44 Cr. (Jun 2025) to 0.53 Cr., marking an increase of 0.09 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.90. The value appears strong and on an upward trend. It has increased from 1.58 (Jun 2025) to 1.90, marking an increase of 0.32.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:06 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.02 | 0.06 | 0.55 | 0.50 | 1.40 | 0.79 | 0.78 | 0.84 | 1.15 | 2.02 | 17.82 | 3.23 | 5.37 |
| Expenses | 0.01 | 0.05 | 0.59 | 0.30 | 1.13 | 0.75 | 1.55 | 1.14 | 0.51 | 2.43 | 16.91 | 1.61 | 2.07 |
| Operating Profit | 0.01 | 0.01 | -0.04 | 0.20 | 0.27 | 0.04 | -0.77 | -0.30 | 0.64 | -0.41 | 0.91 | 1.62 | 3.30 |
| OPM % | 50.00% | 16.67% | -7.27% | 40.00% | 19.29% | 5.06% | -98.72% | -35.71% | 55.65% | -20.30% | 5.11% | 50.15% | 61.45% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.74 | 0.00 | 0.00 | 0.11 | 0.00 | 0.84 | 0.94 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.07 | 0.01 | 0.02 | 0.21 | 0.73 | 0.31 | 0.57 | 1.00 |
| Depreciation | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.13 | 0.13 | 0.14 |
| Profit before tax | 0.01 | 0.01 | -0.05 | 0.19 | 0.23 | -0.03 | 0.96 | -0.32 | 0.43 | -1.13 | 0.47 | 1.76 | 3.10 |
| Tax % | 0.00% | 0.00% | 0.00% | 26.32% | 17.39% | 0.00% | 30.21% | 6.25% | 32.56% | 0.88% | 23.40% | 18.18% | |
| Net Profit | 0.01 | 0.00 | -0.05 | 0.15 | 0.20 | -0.03 | 0.66 | -0.34 | 0.30 | -1.14 | 0.36 | 1.45 | 2.18 |
| EPS in Rs | 0.21 | 0.00 | -0.34 | 1.03 | 1.37 | -0.21 | 4.54 | -2.34 | 2.06 | -5.84 | 1.85 | 5.20 | 8.16 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -100.00% | 400.00% | 33.33% | -115.00% | 2300.00% | -151.52% | 188.24% | -480.00% | 131.58% | 302.78% |
| Change in YoY Net Profit Growth (%) | 0.00% | 500.00% | -366.67% | -148.33% | 2415.00% | -2451.52% | 339.75% | -668.24% | 611.58% | 171.20% |
Bazel International Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 49% |
| 5 Years: | 33% |
| 3 Years: | 41% |
| TTM: | -70% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 17% |
| 3 Years: | 69% |
| TTM: | 1378% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 11% |
| 1 Year: | -13% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 0% |
| 3 Years: | 1% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 2:36 pm
Balance Sheet
Last Updated: December 4, 2025, 2:30 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.49 | 0.49 | 1.46 | 1.46 | 1.46 | 1.46 | 1.46 | 1.46 | 1.46 | 1.95 | 1.95 | 2.79 | 2.79 |
| Reserves | 13.33 | 13.33 | 12.30 | 12.45 | 12.64 | 12.43 | 13.09 | 12.73 | 13.20 | 41.46 | 41.98 | 48.70 | 53.10 |
| Borrowings | 0.00 | 0.03 | 0.00 | 0.50 | 1.09 | 0.25 | 0.02 | 2.58 | 1.98 | 7.66 | 8.72 | 19.23 | 19.95 |
| Other Liabilities | 0.27 | 0.01 | 0.04 | 0.09 | 0.09 | 0.05 | 0.21 | 0.72 | 0.62 | 0.64 | 2.91 | 1.01 | 1.49 |
| Total Liabilities | 14.09 | 13.86 | 13.80 | 14.50 | 15.28 | 14.19 | 14.78 | 17.49 | 17.26 | 51.71 | 55.56 | 71.73 | 77.33 |
| Fixed Assets | 0.00 | 0.00 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.44 | 0.32 | 0.19 | 0.17 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 11.08 | 10.15 | 5.86 | 4.33 | 3.25 | 1.44 | 1.44 | 1.27 | 1.25 | 1.63 | 2.89 | 11.29 | 11.02 |
| Other Assets | 3.01 | 3.71 | 7.92 | 10.16 | 12.02 | 12.75 | 13.34 | 16.22 | 16.01 | 49.64 | 52.35 | 60.25 | 66.14 |
| Total Assets | 14.09 | 13.86 | 13.80 | 14.50 | 15.28 | 14.19 | 14.78 | 17.49 | 17.26 | 51.71 | 55.56 | 71.73 | 77.33 |
Below is a detailed analysis of the balance sheet data for Bazel International Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 2.79 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.79 Cr..
- For Reserves, as of Sep 2025, the value is 53.10 Cr.. The value appears strong and on an upward trend. It has increased from 48.70 Cr. (Mar 2025) to 53.10 Cr., marking an increase of 4.40 Cr..
- For Borrowings, as of Sep 2025, the value is 19.95 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 19.23 Cr. (Mar 2025) to 19.95 Cr., marking an increase of 0.72 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1.49 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.01 Cr. (Mar 2025) to 1.49 Cr., marking an increase of 0.48 Cr..
- For Total Liabilities, as of Sep 2025, the value is 77.33 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 71.73 Cr. (Mar 2025) to 77.33 Cr., marking an increase of 5.60 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.17 Cr.. The value appears to be declining and may need further review. It has decreased from 0.19 Cr. (Mar 2025) to 0.17 Cr., marking a decrease of 0.02 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 11.02 Cr.. The value appears to be declining and may need further review. It has decreased from 11.29 Cr. (Mar 2025) to 11.02 Cr., marking a decrease of 0.27 Cr..
- For Other Assets, as of Sep 2025, the value is 66.14 Cr.. The value appears strong and on an upward trend. It has increased from 60.25 Cr. (Mar 2025) to 66.14 Cr., marking an increase of 5.89 Cr..
- For Total Assets, as of Sep 2025, the value is 77.33 Cr.. The value appears strong and on an upward trend. It has increased from 71.73 Cr. (Mar 2025) to 77.33 Cr., marking an increase of 5.60 Cr..
Notably, the Reserves (53.10 Cr.) exceed the Borrowings (19.95 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.01 | -0.02 | -0.04 | -0.30 | -0.82 | -0.21 | -0.79 | -2.88 | -1.34 | -8.07 | -7.81 | -17.61 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 182.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 315.23 | 1,204.61 |
| Inventory Days | 0.00 | 0.00 | ||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 182.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 315.23 | 1,204.61 |
| Working Capital Days | 33,397.50 | 18,493.33 | 4,778.18 | 6,037.10 | 3,052.96 | 87.78 | -65.51 | -21.73 | -174.57 | 0.00 | 281.23 | 1,367.34 |
| ROCE % | 0.07% | 0.07% | -0.36% | 1.35% | 1.76% | 0.27% | 6.76% | -1.91% | 3.83% | -1.18% | 1.50% | 3.78% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 16 | Mar 15 |
|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 7.59 | 0.02 | -0.41 | 0.02 |
| Diluted EPS (Rs.) | 7.59 | 0.02 | -0.41 | 0.01 |
| Cash EPS (Rs.) | 2.55 | 2.50 | -0.32 | 0.01 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 183.37 | 225.24 | 97.63 | 284.91 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 183.37 | 225.24 | 97.63 | 284.91 |
| Revenue From Operations / Share (Rs.) | 11.50 | 91.19 | 3.87 | 1.34 |
| PBDIT / Share (Rs.) | 5.82 | 4.37 | 0.10 | 0.39 |
| PBIT / Share (Rs.) | 5.35 | 3.70 | 0.05 | 0.39 |
| PBT / Share (Rs.) | 3.22 | 2.40 | -0.32 | 0.39 |
| Net Profit / Share (Rs.) | 2.08 | 1.83 | -0.37 | 0.01 |
| NP After MI And SOA / Share (Rs.) | 3.63 | 1.83 | -0.41 | 0.01 |
| PBDIT Margin (%) | 50.57 | 4.79 | 2.61 | 29.35 |
| PBIT Margin (%) | 46.50 | 4.06 | 1.51 | 29.35 |
| PBT Margin (%) | 27.97 | 2.63 | -8.31 | 29.34 |
| Net Profit Margin (%) | 18.06 | 2.00 | -9.57 | 1.47 |
| NP After MI And SOA Margin (%) | 31.55 | 2.00 | -10.59 | 1.47 |
| Return on Networth / Equity (%) | 1.97 | 0.81 | -0.43 | 0.00 |
| Return on Capital Employeed (%) | 2.57 | 1.60 | 0.05 | 0.13 |
| Return On Assets (%) | 1.28 | 0.64 | -0.40 | 0.00 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.02 | 0.00 |
| Total Debt / Equity (X) | 0.40 | 0.19 | 0.02 | 0.00 |
| Asset Turnover Ratio (%) | 0.04 | 0.00 | 0.03 | 0.00 |
| Current Ratio (X) | 3.11 | 5.21 | 125.77 | 218.98 |
| Quick Ratio (X) | 3.11 | 5.21 | 125.77 | 218.98 |
| Interest Coverage Ratio (X) | 2.73 | 3.35 | 0.26 | 2265.25 |
| Interest Coverage Ratio (Post Tax) (X) | 1.98 | 2.40 | 0.02 | 1753.35 |
| Enterprise Value (Cr.) | 44.55 | 15.52 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 13.90 | 0.87 | 0.00 | 0.00 |
| EV / EBITDA (X) | 27.48 | 18.20 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 5.78 | 0.47 | 0.00 | 0.00 |
| Price / BV (X) | 0.36 | 0.19 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 5.78 | 0.47 | 0.00 | 0.00 |
| EarningsYield | 0.05 | 0.04 | 0.00 | 0.00 |
After reviewing the key financial ratios for Bazel International Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 7.59. This value is within the healthy range. It has increased from 0.02 (Mar 24) to 7.59, marking an increase of 7.57.
- For Diluted EPS (Rs.), as of Mar 25, the value is 7.59. This value is within the healthy range. It has increased from 0.02 (Mar 24) to 7.59, marking an increase of 7.57.
- For Cash EPS (Rs.), as of Mar 25, the value is 2.55. This value is below the healthy minimum of 3. It has increased from 2.50 (Mar 24) to 2.55, marking an increase of 0.05.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 183.37. It has decreased from 225.24 (Mar 24) to 183.37, marking a decrease of 41.87.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 183.37. It has decreased from 225.24 (Mar 24) to 183.37, marking a decrease of 41.87.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 11.50. It has decreased from 91.19 (Mar 24) to 11.50, marking a decrease of 79.69.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 5.82. This value is within the healthy range. It has increased from 4.37 (Mar 24) to 5.82, marking an increase of 1.45.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.35. This value is within the healthy range. It has increased from 3.70 (Mar 24) to 5.35, marking an increase of 1.65.
- For PBT / Share (Rs.), as of Mar 25, the value is 3.22. This value is within the healthy range. It has increased from 2.40 (Mar 24) to 3.22, marking an increase of 0.82.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 2.08. This value is within the healthy range. It has increased from 1.83 (Mar 24) to 2.08, marking an increase of 0.25.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.63. This value is within the healthy range. It has increased from 1.83 (Mar 24) to 3.63, marking an increase of 1.80.
- For PBDIT Margin (%), as of Mar 25, the value is 50.57. This value is within the healthy range. It has increased from 4.79 (Mar 24) to 50.57, marking an increase of 45.78.
- For PBIT Margin (%), as of Mar 25, the value is 46.50. This value exceeds the healthy maximum of 20. It has increased from 4.06 (Mar 24) to 46.50, marking an increase of 42.44.
- For PBT Margin (%), as of Mar 25, the value is 27.97. This value is within the healthy range. It has increased from 2.63 (Mar 24) to 27.97, marking an increase of 25.34.
- For Net Profit Margin (%), as of Mar 25, the value is 18.06. This value exceeds the healthy maximum of 10. It has increased from 2.00 (Mar 24) to 18.06, marking an increase of 16.06.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 31.55. This value exceeds the healthy maximum of 20. It has increased from 2.00 (Mar 24) to 31.55, marking an increase of 29.55.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.97. This value is below the healthy minimum of 15. It has increased from 0.81 (Mar 24) to 1.97, marking an increase of 1.16.
- For Return on Capital Employeed (%), as of Mar 25, the value is 2.57. This value is below the healthy minimum of 10. It has increased from 1.60 (Mar 24) to 2.57, marking an increase of 0.97.
- For Return On Assets (%), as of Mar 25, the value is 1.28. This value is below the healthy minimum of 5. It has increased from 0.64 (Mar 24) to 1.28, marking an increase of 0.64.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.40. This value is within the healthy range. It has increased from 0.19 (Mar 24) to 0.40, marking an increase of 0.21.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.04. It has increased from 0.00 (Mar 24) to 0.04, marking an increase of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 3.11. This value exceeds the healthy maximum of 3. It has decreased from 5.21 (Mar 24) to 3.11, marking a decrease of 2.10.
- For Quick Ratio (X), as of Mar 25, the value is 3.11. This value exceeds the healthy maximum of 2. It has decreased from 5.21 (Mar 24) to 3.11, marking a decrease of 2.10.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.73. This value is below the healthy minimum of 3. It has decreased from 3.35 (Mar 24) to 2.73, marking a decrease of 0.62.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.98. This value is below the healthy minimum of 3. It has decreased from 2.40 (Mar 24) to 1.98, marking a decrease of 0.42.
- For Enterprise Value (Cr.), as of Mar 25, the value is 44.55. It has increased from 15.52 (Mar 24) to 44.55, marking an increase of 29.03.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 13.90. This value exceeds the healthy maximum of 3. It has increased from 0.87 (Mar 24) to 13.90, marking an increase of 13.03.
- For EV / EBITDA (X), as of Mar 25, the value is 27.48. This value exceeds the healthy maximum of 15. It has increased from 18.20 (Mar 24) to 27.48, marking an increase of 9.28.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.78. This value exceeds the healthy maximum of 3. It has increased from 0.47 (Mar 24) to 5.78, marking an increase of 5.31.
- For Price / BV (X), as of Mar 25, the value is 0.36. This value is below the healthy minimum of 1. It has increased from 0.19 (Mar 24) to 0.36, marking an increase of 0.17.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.78. This value exceeds the healthy maximum of 3. It has increased from 0.47 (Mar 24) to 5.78, marking an increase of 5.31.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bazel International Ltd:
- Net Profit Margin: 18.06%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 2.57% (Industry Average ROCE: 15.81%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.97% (Industry Average ROE: 8.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.98
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.11
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 10.1 (Industry average Stock P/E: 50.96)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.4
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 18.06%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | II-B/20, First Floor, New Delhi Delhi 110024 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pankaj Dawar | Managing Director |
| Ms. Prithvi Raj Bhatt | Ind. Non-Executive Director |
| Ms. Pooja Bhardwaj | Ind. Non-Executive Director |
| Mrs. Sriparna Upadhyay | Non Executive Director |
FAQ
What is the intrinsic value of Bazel International Ltd?
Bazel International Ltd's intrinsic value (as of 21 January 2026) is ₹66.32 which is 15.54% higher the current market price of ₹57.40, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹22.1 Cr. market cap, FY2025-2026 high/low of ₹105/53.3, reserves of ₹53.10 Cr, and liabilities of ₹77.33 Cr.
What is the Market Cap of Bazel International Ltd?
The Market Cap of Bazel International Ltd is 22.1 Cr..
What is the current Stock Price of Bazel International Ltd as on 21 January 2026?
The current stock price of Bazel International Ltd as on 21 January 2026 is ₹57.4.
What is the High / Low of Bazel International Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bazel International Ltd stocks is ₹105/53.3.
What is the Stock P/E of Bazel International Ltd?
The Stock P/E of Bazel International Ltd is 10.1.
What is the Book Value of Bazel International Ltd?
The Book Value of Bazel International Ltd is 201.
What is the Dividend Yield of Bazel International Ltd?
The Dividend Yield of Bazel International Ltd is 0.00 %.
What is the ROCE of Bazel International Ltd?
The ROCE of Bazel International Ltd is 3.78 %.
What is the ROE of Bazel International Ltd?
The ROE of Bazel International Ltd is 3.04 %.
What is the Face Value of Bazel International Ltd?
The Face Value of Bazel International Ltd is 10.0.